In this report, we demonstrate that oncogenic RAS signaling can increase tumor cell-intrinsic PD-L1 expression, implying that mutant RAS oncogenes can directly contribute to the evasion of immune destruction in cancer. The gene discussed is CD274; the disease is cancer.